Planned uniQure (NASDAQ: QURE) insider Rule 144 sale totals 6,390 shares

Rhea-AI Filing Summary

uniQure insider plans stock sale under Rule 144

A holder of uniQure N.V. ordinary shares filed a notice of proposed sale under Rule 144 for 6,390 ordinary shares, to be handled through Citigroup Global Markets, Inc. on the NASDAQ exchange. The filing lists an aggregate market value of $174,330.00 for these shares and notes that 62,291,663 ordinary shares were outstanding. The shares are described as acquired through a stock options exercise and sale pursuant to a Rule 10b5-1 trading plan, with cash as the form of payment. The notice also reports that Jack Kaye sold 38,810 ordinary shares during the past three months for $1,177,517.00 in gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	6390	174330.00	62291663	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	01/09/2026	Stock Options Exercise and Sale pursuant to 10B5-1 Plan	UniQure N.A.			6390	01/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jack Kaye paasheuvelweg 25 a Amsterdam P7 1105BP	Ordinary shares	11/04/2025	38810	1177517.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing disclose for QURE?

The notice discloses a proposed sale of 6,390 uniQure N.V. ordinary shares under Rule 144, with an aggregate market value of $174,330.00, to be sold through Citigroup Global Markets, Inc. on NASDAQ.

How many QURE shares are outstanding according to this filing?

The filing states that 62,291,663 ordinary shares of uniQure N.V. were outstanding.

Who is identified as a recent seller of QURE shares in the past 3 months?

The document lists Jack Kaye as a seller of 38,810 ordinary shares of uniQure N.V. on 11/04/2025, with $1,177,517.00 in gross proceeds.

What type of transaction is associated with the new 6,390-share QURE sale?

The 6,390 ordinary shares are described as acquired via a “Stock Options Exercise and Sale pursuant to 10B5-1 Plan”, with cash as the nature of payment.

Which broker is handling the planned sale of QURE shares?

The planned Rule 144 sale of uniQure N.V. ordinary shares is to be executed through Citigroup Global Markets, Inc., located at 390 Greenwich Street, New York, NY 10013.

On which exchange are the QURE shares in this Form 144 expected to be sold?

The filing identifies NASDAQ as the securities exchange for the planned sale of uniQure N.V. ordinary shares.

What representation does the selling person make in this QURE Form 144?

By signing the notice, the selling person represents that they do not know any material adverse information about uniQure N.V.’s current or prospective operations that has not been publicly disclosed.